Subscribe to Newsletter
Business & Regulation Trends & Forecasts, Supply Chain, Standards & Regulation, COVID-19, Advanced Medicine

Video Roundtable: Cell & Gene in a World in Turmoil

From COVID-19 to a cost of living crisis, life over the last few years has been “out of the frying pan and into the fryer” for many of us – but how about the scientists, startups, and stars of cell and gene therapy? What way forward do they see for a field facing down an array of serious technical challenges?

To help answer these far-from-simple questions, we brought in a panel of area experts from Biovectra, Cambridge Consultants, eXmoor Pharma, Ori Biotech, and STRM.BIO. In our conversation, the speakers on our roundtable considered the impact of the rise of mRNA, the chances and challenges posed by automation, and how companies should rank their priorities in the years ahead – to name but a few of the tough questions they got stuck into. You can watch the entire conversation below.


Moderator: Angus Stewart, Associate Editor

  • Jessica Madigan - Business Development Director, BIOVECTRA
  • Rob Collison - VP of Business Development, Cell and Gene Therapy & BioInnovation/MedTech, Cambridge Consultants
  • Angela Osborne - CEO and Founder, eXmoor Pharma
  • Jason C. Foster - CEO and Executive Director, Ori Biotech
  • Jonathan Thon - CEO and Founder, STRM.BIO
Receive content, products, events as well as relevant industry updates from The Medicine Maker and its sponsors.
Stay up to date with our other newsletters and sponsors information, tailored specifically to the fields you are interested in

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].
If you wish to unsubscribe, you can update your preferences at any point.

About the Author
Angus Stewart

Associate Editor of The Medicine Maker

Between studying for my English undergrad and Publishing master's degrees I was out in Shanghai, teaching, learning, and getting extremely lost. Now I'm expanding my mind down a rather different rabbit hole: the pharmaceutical industry. Outside of this job I read mountains of fiction and philosophy, and I must say, it's very hard to tell who's sharper: the literati, or the medicine makers.

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine